Episodio – Depresión atípica y MAO inhibitors: phenelzine en tratamiento resistente | USMLE Step 1 episode artwork

EPISODE · May 12, 2026 · 7 MIN

Episodio – Depresión atípica y MAO inhibitors: phenelzine en tratamiento resistente | USMLE Step 1

from USMLE DREAMERS · host USMLE DREAMERS

Paciente de 44 años con depresión resistente, hipersomnia, hiperfagia, leaden paralysis y rechazo interpersonal: integración completa entre atypical depression, mood reactivity y monoamine oxidase inhibitors como phenelzine para USMLE Step 1. Revisamos MAOIs, serotonin syndrome, tyramine y características clásicas del NBME.Educational podcast, healthcare podcast y health education podcast enfocado en psiquiatría y farmacología del sistema nervioso central.#USMLE #Step1 #Psychiatry #Depression #AtypicalDepression #Phenelzine #MAOI #Neuropharmacology #MoodReactivity #USMLEDreamers #EducationalPodcast #HealthcarePodcast #HealthEducationPodcast

Episode metadata supplied by the publisher feed · Published May 12, 2026

Embed this episode

NOW PLAYING

Episodio – Depresión atípica y MAO inhibitors: phenelzine en tratamiento resistente | USMLE Step 1

0:00 7:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of USMLE DREAMERS?

This episode is 7 minutes long.

When was this USMLE DREAMERS episode published?

This episode was published on May 12, 2026.

Can I download this USMLE DREAMERS episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!